Sage Journals: Discover world-class research

Abstract

This quantitatively driven sequential mixed methods study articulates the role of theory in mixed methods research and assesses the contribution of a mixed methods design to examining gender differences in men and women’s genetic testing decisions and the psychosocial factors impacting health-seeking behaviors post-testing. A quantitative online survey of BRCA-positive mutation men and women was followed by a qualitative component consisting of semi-structured telephone interviews regarding genetic testing and post-testing decision making. Findings reveal gender differences in testing motivations: women focus on health; men focus on their family’s needs. Gender differences also appeared in psychological states and surgical decisions, revealing women’s more negative psychosocial reactions to a positive BRCA test result and higher rate of selecting preventative surgery.

Keywords

BRCA1/2 gender differences genetic testing hereditary breast cancer theoretically grounded MMR

Get full access to this article

View all access options for this article.

References

Addis

M. E.

Mahalik

J. R.

(2003). Men, masculinity, and the contexts of help seeking. American Psychologist, 58, 5-14.

Agalliu

Karlins

Kwon

E. M.

Iwasaki

L. M.

Diamond

Ostrander

E. A.

Stanford

J. L.

(2007). Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. British Journal of Cancer, 97, 826-831.

Agrawal

Ayantunde

A. A.

Rampaul

Robertson

J. F.

(2007). Male breast cancer: A review of clinical management. Breast Cancer Research and Treatment, 103, 11-21.

American Cancer Society. (2011). Breast Cancer Facts & Figures 2011-2012. Retrieved from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-030975.pdf

American Cancer Society. (2013). Cancer Facts & Figures 2013. Retrieved from http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index

Azodi

M. Z.

Ardestani

Dolat

Mousavi

Fayazfar

Shadloo

(2012). Breast cancer: Genetics, risk factors, molecular pathology and treatment. Journal of Paramedical Sciences, 4(1), 1-9.

Bottorff

J. L.

Oliffe

J. L.

Kelly

(2012). The gender(s) in the room. Qualitative Health Research, 22, 435-440.

Bottorff

J. L.

Oliffe

J. L.

Robinson

C. A.

Carey

(2011). Gender relations and health research: A review of current practices. International Journal of Equity in Health, 10(60). doi:10.1186/1475-9276-10-60

Bryant

Charmaz

(2007). Grounded theory in historical perspective: An epistemological account. In Bryant

Charmaz

(Eds.), The Sage handbook of grounded theory (pp. 3-30). Thousand Oaks, CA: Sage.

10.

Cella

Hughes

Peterman

Chang

C. H.

Peshkin

B. N.

Schwartz

M. D.

. . . Lerman

(2002). A brief assessment of concerns associated with genetic testing for cancer: The Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychology, 21, 564-572.

11.

Courtenay

W. H.

(2000). Constructions of masculinity and their influence on men’s well-being: A theory of gender and health. Social Science & Medicine, 50, 1385-1401.

12.

Crabtree

B. F.

Miller

W. L.

(1999). Using codes and code manuals: A template organizing style of interpretation. In Crabtree

B. F.

Miller

W. L.

(Eds.), Doing qualitative research (2nd ed., pp. 163-177). Thousand Oaks, CA: Sage.

13.

Crabtree

B. F.

Miller

W. L.

(Eds.). (1992). Doing qualitative research. Newbury Park, CA: Sage.

14.

Creswell

J. W.

Plano Clark

V. L.

(2011). Designing and conducting mixed methods research (2nd ed.). Thousand Oaks, CA: Sage.

15.

D’Agincourt-Canning

(2001). Experiences of genetic risk: Disclosure and the gendering of responsibility. Bioethics, 15, 231-247.

16.

Daly

M. B.

(2009). The impact of social roles on the experience of men in BRCA1/2 families: Implications for counseling. Journal of Genetic Counseling, 18, 42-48.

17.

Esplen

M. J.

Stuckless

Hunter

Liede

Metcalfe

Glendon

. . . Irwin

(2009). The BRCA Self-Concept Scale: A new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology, 18, 1216-1229.

18.

Evans

B. C.

Coon

D. W.

Ume

(2011). Use of theoretical frameworks as a pragmatic guide for mixed methods studies: A methodological necessity. Journal of Mixed Methods Research, 5(4), 276-292.

19.

Evans

D. G. R.

Binchy

Shenton

Hopwood

Craufurd

(2009). Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clinical Genetics, 75, 124-132.

20.

Fetters

M. D.

Curry

L. A.

Creswell

J. W.

(2013). Achieving integration in mixed methods designs—Principles and practices. Health Services Research, 48(6 Pt. 2), 2134-2156.

21.

Finkler

Skrzynia

Evans

J. P.

(2003). The new genetics and its consequences for family, kinship, medicine and medical genetics. Social Science & Medicine, 57, 403-412.

22.

Freshwater

Fisher

(2015). Mixed methods dissonance and values in research with marginalized groups. In Hesse-Biber

Burke Johnson

(Eds.), The Oxford handbook of multimethod and mixed methods research inquiry (pp. 665-676). New York, NY: Oxford University Press.

23.

Fricker

R. D.

Schonlau

(2012). Advantages and disadvantages of Internet research surveys: Evidence from the literature. In Hughes

(Ed.), Sage Internet research methods (Vol. 2, pp. 1-20). London, England: Sage.

24.

Gerson

J. M.

Peiss

(1985). Boundaries, negotiation, consciousness: Reconceptualizing gender relations. Social Problems, 32, 317-331.

25.

Gómez-Raposo

Tévar

F. Z.

Moyano

M. S.

Gómez

M. L.

Casado

(2010). Male breast cancer. Cancer Treatment Reviews, 36, 451-457.

26.

Hallowell

Ardern-Jones

Eeles

Foster

Lucassen

Moynihan

Watson

(2005). Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: Patterns, priorities and problems. Clinical Genetics, 67, 492-502.

27.

Harding

(2003). How standpoint methodology informs philosophy of social science. In Turner

S. P.

Roth

P. A.

(Eds.), The Blackwell guide to the philosophy of the social sciences (pp. 291-310). New York, NY: Blackwell.

28.

Hartsock

N. C.

(1983). The feminist standpoint: Developing the ground for a specifically feminist historical materialism. In Harding

Hintikka

(Eds.), Discovering reality (pp. 283-310). Dordrecht, Netherlands: Reidel/Kluwer.

29.

Hesse-Biber

(Ed.) (2007). Handbook of feminist research. Thousand Oaks, CA: Sage Publications.

30.

Hesse-Biber

(2010). Mixed methods research: Merging theory with practice. New York, NY: Guilford Press.

31.

Hesse-Biber

(2014). Waiting for cancer to come: Women’s experiences with genetic testing and medical decision making for breast and ovarian cancer. Ann Arbor: University of Michigan Press.

32.

King

(2004). Using templates in the thematic analysis of text. In Symon

Cassell

(Eds.), Essential guide to qualitative methods in organizational research (pp. 256-270). London, England: Sage.

33.

Levy-Lahad

Friedman

(2007). Cancer risks among BRCA1 and BRCA2 mutation carriers. British Journal of Cancer, 96, 11-15.

34.

Liede

Metcalfe

Hanna

Hoodfar

Snyder

Durham

. . . Narod

S. A.

(2000). Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67, 1494-1504.

35.

Lobb

E. A.

Gaff

C. L.

Meiser

Butow

P. N.

Osseiran-Moisson

Hallowell

(2009). Attendance of men at the familial cancer clinic: What they value from the consultation. Genetics in Medicine, 11, 434-440.

36.

Lodder

Frets

P. G.

Trijsburg

R. W.

Tibben

Meijers-Heijboer

E. J.

Duivenvoorden

H. J.

. . . Niermeijer

M. F.

(2001). Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: An exploration of attitudes and psychological functioning during genetic testing. European Journal of Human Genetics, 9, 492-500.

37.

Maxwell

(2016). Expanding the history and range of mixed methods research. Journal of Mixed Methods Research, 10(1), 12-27.

38.

Mersch

Jackson

M. A.

Park

Nebgen

Peterson

S. K.

Singletary

. . . Litton

J. K.

(2015). Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer, 121, 269-275.

39.

Messerschmidt

J. W.

(1993). Masculinities and crime: Critique and reconceptualization of theory. Lanham, MD: Rowman & Littlefield.

40.

Mohamad

H. B.

Apffelstaedt

J. P.

(2008). Counseling for male BRCA mutation carriers: A review. Breast, 17, 441-450.

41.

Narod

S. A.

Neuhausen

Vichodez

Armel

Lynch

H. T.

Ghadirian

. . . Sun

(2008). Rapid progression of prostate cancer in men with a BRCA2 mutation. British Journal of Cancer, 99, 371-374.

42.

O’Brien

Hunt

Hart

(2005). “It’s caveman stuff, but that is to a certain extent how guys still operate”: Men’s accounts of masculinity and help seeking. Social Science & Medicine, 61, 503-516.

43.

Pituskin

Williams

Martin-McDonald

(2007). Experiences of men with breast cancer: A qualitative study. Journal of Men’s Health & Gender, 4, 44-51.

44.

Pleck

J. H.

(1987). The myth of masculinity (3rd ed.). Cambridge: MIT Press.

45.

Saltonstall

(1993). Healthy bodies, social bodies: Men’s and women’s concepts and practices of health in everyday life. Social Science & Medicine, 36, 7-14.

46.

Scott

S. E.

Grunfeld

E. A.

Main

McGurk

(2006). Patient delay in oral cancer: A qualitative study of patients’ experiences. Psycho-Oncology, 15, 474-485.

47.

Shannon-Baker

(2015). Making paradigms meaningful in mixed methods research. Journal of Mixed Methods Research. Advance online publication. doi:10.1177/1558689815575861

48.

Sorenson

J. R.

Botkin

J. R.

(2003). Genetic testing and the family. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 199C, 1-2.

49.

Stöppler

M. C.

Lee

Shiel

W. C.

Jr. (2011). Male breast cancer. Retrieved from http://www.medicinenet.com/male_breast_cancer/article.htm

50.

Strømsvik

Råheim

Øyen

Engebretsen

L. F.

Gjengedal

(2010). Stigmatization and male identity: Norwegian males’ experience after identification as BRCA1/2 mutation carriers. Journal of Genetic Medicine, 19, 360-370.

51.

Strømsvik

Råheim

Øyen

Gjengedal

(2009). Men in the women’s world of hereditary breast and ovarian cancer: A systematic review. Familial Review, 8, 221-229.

52.

Susan G. Komen for the Cure. (n.d.). Preventive surgery reduces cancer risk in women with BRCA1 or BRCA2 mutations. Retrieved from http://ww5.komen.org/Breast-Cancer-News/Preventive-Surgery-Reduces-Cancer-Risk-in-Women-with-BRCA1-or-BRCA2-Mutations.html

53.

Tai

Y. C.

Domchek

Parmigiani

Chen

(2007). Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute, 99, 1811-1814.

54.

Teddlie

Tashakkori

(2011). Mixed methods research: Contemporary issues in an emerging field. In Denzin

N. K.

Lincoln

Y. S.

(Eds.), The Sage handbook of qualitative research (4th ed., pp. 285-299). Thousand Oaks, CA: Sage.

55.

Ward

Jemal

Cokkinides

Singh

G. K.

Cardinez

Ghafoor

Thun

(2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: A Cancer Journal for Clinicians, 54, 78-93.

56.

Welkenhuysen

Evers-Kiebooms

Decruyenaere

Claes

Denayer

(2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. Journal of Medical Genetics, 38, 540-547.

57.

Wenger

L. M.

Oliffe

J. L.

(2013). Moving beyond the prostate: Benefits in broadening the scope of research on men and cancer. American Journal of Men’s Health, 8, 138-141.

58.

Wenger

L. M.

Oliffe

J. L.

(2014). Men managing cancer: A gender analysis. Sociology of Health & Illness, 36, 108-122.

Gender Differences in Psychosocial and Medical Outcomes Stemming From Testing Positive for the BRCA1/2 Genetic Mutation for Breast Cancer: An Explanatory Sequential Mixed Methods Study

Abstract

Keywords

Get full access to this article

References